Sign in to view content

Progression of diabetic retinopathy in patients treated with 0.2 μg/day

Raymond Iezzi, MD, MS

Video
Published 2017

Related

Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Switching to Combination OPT-302 With Aflibercept From Prior Anti-VEGF-A Monotherapy in Eyes With Persistent Diabetic Macula Edema (DME)
David S. Boyer, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more